Auditor Anita Narula has an investigative approach and is meticulous in her observations. She lays special emphasis on the importance of batch testing, environmental monitoring, and sterility technique compliance. She also focuses on the validation of processes, particularly in the areas of sterility and cleanliness.

FDA auditor Anita Narula primarily focuses on sterility and cleanliness aspects, with keen interest in cleaning protocols, sterility testing, and aseptic techniques. She appears to be stringent about processing environments and is highly keen on adherence to proper attire during drug production. Furthermore, auditor Narula tends to ensure that expiration dates are backed by appropriate data and stability programs. She also emphasizes on regular and thorough environmental monitoring.